Report Detail
Global Anticoagulant Medicines Market Growth (Status and Outlook) 2022-2028
- RnM4391729 |
- 06 March, 2022 |
- Global |
- 110 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
As the global economy mends, the 2021 growth of Anticoagulant Medicines will have significant change from previous year. According to our (LP Information) latest study, the global Anticoagulant Medicines market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Anticoagulant Medicines market size will reach USD million in 2028, growing at a CAGR of % over the analysis period.
The United States Anticoagulant Medicines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Anticoagulant Medicines market, reaching US$ million by the year 2028. As for the Europe Anticoagulant Medicines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Anticoagulant Medicines players cover Abbott Laboratories, Aspen, AstraZeneca, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Anticoagulant Medicines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Injectable Anticoagulant Medicines
Oral Anticoagulant Medicines
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Abbott Laboratories
Aspen
AstraZeneca
Bayer
Boehringer Ingelheim
Bristol-Myers Squibb
Daiichi Sankyo
Genentech (Roche)
Johnson & Johnson.
Lilly
Merck
Otsuka
Pfizer
Sanofi
The Medicines Company
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Anticoagulant Medicines Market Size 2017-2028
- 2.1.2 Anticoagulant Medicines Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Anticoagulant Medicines Segment by Type
- 2.2.1 Injectable Anticoagulant Medicines
- 2.2.2 Oral Anticoagulant Medicines
- 2.3 Anticoagulant Medicines Market Size by Type
- 2.3.1 Anticoagulant Medicines Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Anticoagulant Medicines Market Size Market Share by Type (2017-2022)
- 2.4 Anticoagulant Medicines Segment by Application
- 2.4.1 Hospital Pharmacies
- 2.4.2 Retail Pharmacies
- 2.4.3 Online Pharmacies
- 2.4.4 Others
- 2.5 Anticoagulant Medicines Market Size by Application
- 2.5.1 Anticoagulant Medicines Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Anticoagulant Medicines Market Size Market Share by Application (2017-2022)
3 Anticoagulant Medicines Market Size by Player
- 3.1 Anticoagulant Medicines Market Size Market Share by Players
- 3.1.1 Global Anticoagulant Medicines Revenue by Players (2020-2022)
- 3.1.2 Global Anticoagulant Medicines Revenue Market Share by Players (2020-2022)
- 3.2 Global Anticoagulant Medicines Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Anticoagulant Medicines by Regions
- 4.1 Anticoagulant Medicines Market Size by Regions (2017-2022)
- 4.2 Americas Anticoagulant Medicines Market Size Growth (2017-2022)
- 4.3 APAC Anticoagulant Medicines Market Size Growth (2017-2022)
- 4.4 Europe Anticoagulant Medicines Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Anticoagulant Medicines Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Anticoagulant Medicines Market Size by Country (2017-2022)
- 5.2 Americas Anticoagulant Medicines Market Size by Type (2017-2022)
- 5.3 Americas Anticoagulant Medicines Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Anticoagulant Medicines Market Size by Region (2017-2022)
- 6.2 APAC Anticoagulant Medicines Market Size by Type (2017-2022)
- 6.3 APAC Anticoagulant Medicines Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Anticoagulant Medicines by Country (2017-2022)
- 7.2 Europe Anticoagulant Medicines Market Size by Type (2017-2022)
- 7.3 Europe Anticoagulant Medicines Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Anticoagulant Medicines by Region (2017-2022)
- 8.2 Middle East & Africa Anticoagulant Medicines Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Anticoagulant Medicines Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Anticoagulant Medicines Market Forecast
- 10.1 Global Anticoagulant Medicines Forecast by Regions (2023-2028)
- 10.1.1 Global Anticoagulant Medicines Forecast by Regions (2023-2028)
- 10.1.2 Americas Anticoagulant Medicines Forecast
- 10.1.3 APAC Anticoagulant Medicines Forecast
- 10.1.4 Europe Anticoagulant Medicines Forecast
- 10.1.5 Middle East & Africa Anticoagulant Medicines Forecast
- 10.2 Americas Anticoagulant Medicines Forecast by Country (2023-2028)
- 10.2.1 United States Anticoagulant Medicines Market Forecast
- 10.2.2 Canada Anticoagulant Medicines Market Forecast
- 10.2.3 Mexico Anticoagulant Medicines Market Forecast
- 10.2.4 Brazil Anticoagulant Medicines Market Forecast
- 10.3 APAC Anticoagulant Medicines Forecast by Region (2023-2028)
- 10.3.1 China Anticoagulant Medicines Market Forecast
- 10.3.2 Japan Anticoagulant Medicines Market Forecast
- 10.3.3 Korea Anticoagulant Medicines Market Forecast
- 10.3.4 Southeast Asia Anticoagulant Medicines Market Forecast
- 10.3.5 India Anticoagulant Medicines Market Forecast
- 10.3.6 Australia Anticoagulant Medicines Market Forecast
- 10.4 Europe Anticoagulant Medicines Forecast by Country (2023-2028)
- 10.4.1 Germany Anticoagulant Medicines Market Forecast
- 10.4.2 France Anticoagulant Medicines Market Forecast
- 10.4.3 UK Anticoagulant Medicines Market Forecast
- 10.4.4 Italy Anticoagulant Medicines Market Forecast
- 10.4.5 Russia Anticoagulant Medicines Market Forecast
- 10.5 Middle East & Africa Anticoagulant Medicines Forecast by Region (2023-2028)
- 10.5.1 Egypt Anticoagulant Medicines Market Forecast
- 10.5.2 South Africa Anticoagulant Medicines Market Forecast
- 10.5.3 Israel Anticoagulant Medicines Market Forecast
- 10.5.4 Turkey Anticoagulant Medicines Market Forecast
- 10.5.5 GCC Countries Anticoagulant Medicines Market Forecast
- 10.6 Global Anticoagulant Medicines Forecast by Type (2023-2028)
- 10.7 Global Anticoagulant Medicines Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Information
- 11.1.2 Abbott Laboratories Anticoagulant Medicines Product Offered
- 11.1.3 Abbott Laboratories Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Abbott Laboratories Main Business Overview
- 11.1.5 Abbott Laboratories Latest Developments
- 11.2 Aspen
- 11.2.1 Aspen Company Information
- 11.2.2 Aspen Anticoagulant Medicines Product Offered
- 11.2.3 Aspen Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Aspen Main Business Overview
- 11.2.5 Aspen Latest Developments
- 11.3 AstraZeneca
- 11.3.1 AstraZeneca Company Information
- 11.3.2 AstraZeneca Anticoagulant Medicines Product Offered
- 11.3.3 AstraZeneca Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 AstraZeneca Main Business Overview
- 11.3.5 AstraZeneca Latest Developments
- 11.4 Bayer
- 11.4.1 Bayer Company Information
- 11.4.2 Bayer Anticoagulant Medicines Product Offered
- 11.4.3 Bayer Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Bayer Main Business Overview
- 11.4.5 Bayer Latest Developments
- 11.5 Boehringer Ingelheim
- 11.5.1 Boehringer Ingelheim Company Information
- 11.5.2 Boehringer Ingelheim Anticoagulant Medicines Product Offered
- 11.5.3 Boehringer Ingelheim Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Boehringer Ingelheim Main Business Overview
- 11.5.5 Boehringer Ingelheim Latest Developments
- 11.6 Bristol-Myers Squibb
- 11.6.1 Bristol-Myers Squibb Company Information
- 11.6.2 Bristol-Myers Squibb Anticoagulant Medicines Product Offered
- 11.6.3 Bristol-Myers Squibb Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Bristol-Myers Squibb Main Business Overview
- 11.6.5 Bristol-Myers Squibb Latest Developments
- 11.7 Daiichi Sankyo
- 11.7.1 Daiichi Sankyo Company Information
- 11.7.2 Daiichi Sankyo Anticoagulant Medicines Product Offered
- 11.7.3 Daiichi Sankyo Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Daiichi Sankyo Main Business Overview
- 11.7.5 Daiichi Sankyo Latest Developments
- 11.8 Genentech (Roche)
- 11.8.1 Genentech (Roche) Company Information
- 11.8.2 Genentech (Roche) Anticoagulant Medicines Product Offered
- 11.8.3 Genentech (Roche) Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Genentech (Roche) Main Business Overview
- 11.8.5 Genentech (Roche) Latest Developments
- 11.9 Johnson & Johnson.
- 11.9.1 Johnson & Johnson. Company Information
- 11.9.2 Johnson & Johnson. Anticoagulant Medicines Product Offered
- 11.9.3 Johnson & Johnson. Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Johnson & Johnson. Main Business Overview
- 11.9.5 Johnson & Johnson. Latest Developments
- 11.10 Lilly
- 11.10.1 Lilly Company Information
- 11.10.2 Lilly Anticoagulant Medicines Product Offered
- 11.10.3 Lilly Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Lilly Main Business Overview
- 11.10.5 Lilly Latest Developments
- 11.11 Merck
- 11.11.1 Merck Company Information
- 11.11.2 Merck Anticoagulant Medicines Product Offered
- 11.11.3 Merck Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Merck Main Business Overview
- 11.11.5 Merck Latest Developments
- 11.12 Otsuka
- 11.12.1 Otsuka Company Information
- 11.12.2 Otsuka Anticoagulant Medicines Product Offered
- 11.12.3 Otsuka Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Otsuka Main Business Overview
- 11.12.5 Otsuka Latest Developments
- 11.13 Pfizer
- 11.13.1 Pfizer Company Information
- 11.13.2 Pfizer Anticoagulant Medicines Product Offered
- 11.13.3 Pfizer Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 Pfizer Main Business Overview
- 11.13.5 Pfizer Latest Developments
- 11.14 Sanofi
- 11.14.1 Sanofi Company Information
- 11.14.2 Sanofi Anticoagulant Medicines Product Offered
- 11.14.3 Sanofi Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 Sanofi Main Business Overview
- 11.14.5 Sanofi Latest Developments
- 11.15 The Medicines Company
- 11.15.1 The Medicines Company Company Information
- 11.15.2 The Medicines Company Anticoagulant Medicines Product Offered
- 11.15.3 The Medicines Company Anticoagulant Medicines Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 The Medicines Company Main Business Overview
- 11.15.5 The Medicines Company Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Anticoagulant Medicines. Industry analysis & Market Report on Anticoagulant Medicines is a syndicated market report, published as Global Anticoagulant Medicines Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Anticoagulant Medicines market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
